N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
Martedì 16 marzo 2021
circa 1 minuti di lettura
Journal and Affiliations:
Cell, 16 marzo 2021
Anna De Marco, Humabs BioMed, Bellinzona
Dora Pinto, Humabs BioMed, Bellinzona
Martina Beltramello, Humabs BioMed, Bellinzona
Fabrizia Zatta, Humabs BioMed, Bellinzona
Siro Bianchi, Humabs BioMed, Bellinzona
Barbara Guarino, Humabs BioMed, Bellinzona
Chiara Silacci Fregni, Humabs BioMed, Bellinzona
Fabio Benigni, Humabs BioMed, Bellinzona
Elisabetta Cameroni, Humabs BioMed, Bellinzona
Davide Corti, Humabs BioMed, Bellinzona
Matteo Samuele Pizzuto, Humabs BioMed, Bellinzona
Tags:
COVID-19
memory B cells
N-terminal domain
neutralizing antibody
NTD
SARS-CoV-2
spike glycoprotein
Authors:
Anna De Marco
Barbara Guarino
Chiara Silacci Fregni
Davide Corti
Dora Pinto
Elisabetta Cameroni
Fabio Benigni
Fabrizia Zatta
Martina Beltramello
Matteo Samuele Pizzuto
Siro Bianchi